Africa Eastern and Southern vs United Kingdom: Antiretroviral therapy coverage
Africa Eastern and Southern
83.9%
in 2024
United Kingdom
94.0%
in 2023
Africa Eastern and Southern rank
4th
United Kingdom rank
7th
Antiretroviral therapy coverage over time
- Africa Eastern and Southern
- United Kingdom
How they compare
United Kingdom currently reports 94.0% against 83.9% in Africa Eastern and Southern, a difference of 10.1%.
That makes United Kingdom's figure about 1.1 times Africa Eastern and Southern's.
Across all 8 years both countries report, United Kingdom has been ahead every year.
Africa Eastern and Southern ranks 4th and United Kingdom ranks 7th of 23 groups.
United Kingdom has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Africa Eastern and Southern | United Kingdom | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 65.5% | 91.0% | 25.5% | United Kingdom |
| 2020s | 77.8% | 92.2% | 14.4% | United Kingdom |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage, Africa Eastern and Southern or United Kingdom?
- United Kingdom, at 94.0% against 83.9% in Africa Eastern and Southern as of 2023.
- What is the difference in antiretroviral therapy coverage between Africa Eastern and Southern and United Kingdom?
- 10.1%, with United Kingdom ahead.
- How many years of comparable data are there for Africa Eastern and Southern and United Kingdom?
- 8 years are reported by both, from 2016 to 2023.
- How do Africa Eastern and Southern and United Kingdom rank globally for antiretroviral therapy coverage?
- Africa Eastern and Southern ranks 4th and United Kingdom ranks 7th of 23 groups.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.